Acute Effects of a Whole Body Vibration Session on the Vibration Perception Threshold in Patients with Type 2 Diabetes Mellitus

Background: Type 2 Diabetes Mellitus (T2DM) is a chronic disease that affects millions of people, and according to the International Diabetes Federation, 46.5% of people have undiagnosed diabetes. One of the most common complications of diabetes mellitus is loss of peripheral sensation. Whole Body V...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of environmental research and public health Vol. 17; no. 12; p. 4356
Main Authors Dominguez-Muñoz, Francisco Javier, Hernandez-Mocholi, Miguel Angel, Villafaina, Santos, García-Gordillo, Miguel Angel, Collado-Mateo, Daniel, Gusi, Narcis, Adsuar, Jose Carmelo
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 18.06.2020
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Type 2 Diabetes Mellitus (T2DM) is a chronic disease that affects millions of people, and according to the International Diabetes Federation, 46.5% of people have undiagnosed diabetes. One of the most common complications of diabetes mellitus is loss of peripheral sensation. Whole Body Vibration (WBV) is a therapy, and it would be interesting to know if it can be considered as a training method to improve the Vibration Perception Threshold (VPT). The aim of the study is to verify whether there are really acute effects on the VPT after a WBV training session in people with T2DM. Methods: Ninety people with T2DM (56 men and 34 women) were randomly allocated to two groups: the WBV group and the placebo group. The ninety subjects went through a VPT training test before receiving the assigned intervention, and they performed the VPT test using the Vibratron II device. Results: After one session of WBV, an increase of the VPT in the WBV group was found, with respect to the placebo group. Conclusions: Vibration perception threshold is increased after a WBV training session in people with T2DM, compared to a placebo group.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph17124356